Michael Lee Brooks - Feb 16, 2022 Form 4 Insider Report for Syneos Health, Inc. (SYNH)

Role
Chief Development Officer & Global Head Clinical Development Solutions
Signature
/s/ Jonathan Olefson, Attorney-in-Fact
Stock symbol
SYNH
Transactions as of
Feb 16, 2022
Transactions value $
-$320,724
Form type
4
Date filed
2/18/2022, 04:07 PM
Previous filing
Jan 20, 2022
Next filing
Mar 4, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SYNH Class A Common Stock Tax liability -$321K -3.85K -9.79% $83.37 35.5K Feb 16, 2022 Direct
holding SYNH Class A Common Stock 10.8K Feb 16, 2022 By spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Chief Development Officer & Global Head Clinical Development Solutions